Latest Research in Pharmaceutical Practices and Patient Outcomes

Top Research Topics in Pharmaceutical Practices and Patient Outcomes

• Pharmaceutical Practices and Patient Outcomes — 32 papers
• Forensic Toxicology and Drug Analysis — 15 papers
• Opioid Use Disorder Treatment — 5 papers
• Medication Adherence and Compliance — 4 papers
• Veterinary Pharmacology and Anesthesia — 4 papers
• Antibiotic Use and Resistance — 3 papers
• Chronic Disease Management Strategies — 3 papers
• Pharmacovigilance and Adverse Drug Reactions — 2 papers
• Cannabis and Cannabinoid Research — 2 papers
• Poisoning and overdose treatments — 2 papers

Highest-Cited Papers

1. Trends in opioid containing drug seizures described as pills between 2020 and 2024 in Canada
2. Potentially inappropriate medication use and selected drug-related problems among older adults in Aseer Region, Saudi Arabia: a retrospective multicenter study
3. Impact of telemedicine on minimizing polypharmacy in older adult patients receiving primary care: a systematic review
4. Community Pharmacist Support for Complex Palliative Pharmacotherapy and Home Infusion in Advanced Heart Failure: A Case Report
5. “A better system” – managing the adverse effects of prescribed medicines: Cluster-randomised controlled trial and process evaluation of the ADRe Profile in primary care
6. Insights About Nitazene Use From Self-reported Experiences on Reddit Obtained Using Natural Language Processing
7. Pills and Perils: Navigating Polypharmacy in Older Adults.
8. Implications of self-medication among socially vulnerable older adults in the COVID-19 era (2021–2023)
9. Knowledge and Beliefs Surrounding Nalmefene Among Alabama Pharmacists: A Cross-Sectional Survey Informed by the Theory of Planned Behavior
10. Establishing quality prescribing indicators for Australian primary care: a Delphi study
11. Development of a Core Outcome Measurement Set for studies of community pharmacist-led medication reviews in older patients with multimorbidity and polypharmacy
12. Management of Patients with Medetomidine Withdrawal During Interfacility Transfer
13. Factors associated with medication concerns for those living with bipolar disorder and significant others
14. Global under- and overprescribing of drugs—a scoping review
15. Prescription Drug Use Among US Adults
16. Response to Letter ‘Polypharmacy and Oral Health in Older Adults: Measure Anticholinergic and Sedative Burden, Not Pill Count Alone’
17. Pharmacist intervention to improve medication adherence in patients with depressive disorder: A scoping review
18. A Survey of Cannabigerol User’s Patterns of Use, Perceived Efficacy and Satisfaction
19. “Rhino Tranq” in Connecticut—Prevalence of Medetomidine in the Fentanyl Supply Varies by Data Source
20. Differences in Anticholinergic Exposure Assessment Across Burden Scales and Exposure Measures in a Population-Based Study: Implications for Targeted Deprescribing in Older Adults